The Case for Early Initiation of Monotherapies and Delayed Dopaminergic Therapy in Parkinson's Disease

Supplements and Featured PublicationsThe Case for Early Initiation of Monotherapies and Delayed Dopaminergic Therapy in Parkinson's Disea
Volume 17
Issue 12 Suppl

After reading "The Case for Early Initiation of Monotherapies and Delayed Dopaminergic Therapy in Parkinson’s Disease,” participants must complete the online evaluation form and achieve a passing score of 70% or higher on the online posttest. Upon submission of the completed evaluation and posttest, participants may print their statement of credit.

TAKE PHYSICIAN CME TEST

TAKE PHARMACIST CE TEST

© 2023 MJH Life Sciences
AJMC®
All rights reserved.